C. Jordán de Luna

ORCID: 0000-0002-2249-3606
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • Cancer survivorship and care
  • Drug Transport and Resistance Mechanisms
  • Clinical practice guidelines implementation
  • Pharmacological Effects and Toxicity Studies
  • Neutropenia and Cancer Infections
  • Neonatal Health and Biochemistry
  • Pharmaceutical Economics and Policy
  • Delphi Technique in Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Palliative Care and End-of-Life Issues
  • Patient-Provider Communication in Healthcare
  • Methemoglobinemia and Tumor Lysis Syndrome
  • Transplantation: Methods and Outcomes
  • Economic and Financial Impacts of Cancer
  • Organ Transplantation Techniques and Outcomes
  • Hemoglobinopathies and Related Disorders

Institut Català d'Oncologia
2018-2022

Universitat de Barcelona
2022

Hospital Universitari i Politècnic La Fe
2011-2015

Instituto de Investigación Sanitaria La Fe
2015

Aim: Studying the possible influence of SNPs on efficacy and safety calcineurin inhibitors upon heart transplantation. Materials & methods: In 60 transplant patients treated with tacrolimus or cyclosporine, we studied a panel 36 correlated series clinical parameters during first post-transplantation year. Results: The presence serious infections was to ABCB1 rs1128503 (p = 0.012), CC genotype reduced probability being also associated lower blood cyclosporine concentrations. Lower renal...

10.2217/pgs.15.39 article EN Pharmacogenomics 2015-06-01

Abstract Objective Cancer is one of the biggest health challenges our times, affecting all personal areas a patient. The interrelationships between these and need for multidisciplinary care require assessment psychosocial complexity in cancer patients. main aim this study was to reach consensus on general definition its elements according experts field. Method A Delphi performed, which first involved comprehensive review literature create questionnaire that validated by two expert panels....

10.1017/s1478951520000784 article EN Palliative & Supportive Care 2020-08-25

In the process of determining if a drug is valuable enough to be included in hospital's pharmacotherapeutic repertoire many factors should taken into account. order develop guide, methodology different appraisal working groups and similar methodological documents published by Health Technology Assessment agencies have been We recommend that reports are structured with following headings: Medication/Description/Authorised indication; Description disease; Pathology reference treatment;...

10.1136/ejhpharm-2018-001593 article EN European Journal of Hospital Pharmacy 2018-11-16
Coming Soon ...